Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × eprenetapopt × Clear all

NCT02098343 2025-03-17

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Phase 1/2 Completed

247 enrolled 15 charts

Ovarian Neoplasms, Recurrence